Department of Oncology, Cancer Prevention & Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 2115 Wisconsin Avenue, NW Suite 300, Washington, DC 20007, United States.
Department of Medicine, University of Miami Sylvester Comprehensive Cancer Center, Jackson Memorial Hospital, 1475 NW 12th Ave, Miami, FL 33136, United States.
Lung Cancer. 2022 Jul;169:55-60. doi: 10.1016/j.lungcan.2022.05.008. Epub 2022 May 17.
The United States Preventive Services Task Force (USPSTF) recommendations do not account for race and sex differences in lung cancer risk. We compared the sensitivity for finding lung cancer cases eligible for lung cancer screening (LCS) by USPSTF 2013 recommendations versus the PLCOm2012 model at an equivalent threshold.
Using Georgetown University Hospital tumor registry, we identified lung cancer cases (≥55 years old) between 2014 and 2018. Medical chart review collected age, sex, race, education, smoking, and clinical characteristics. We compared the percentage meeting eligibility criteria overall, and by race and sex.
The cases (N = 447) were 36.6% Black and 52.6% female. The PLCOm2012 and USPSTF 2013 criteria identified 71.4% and 45.6% of cases, respectively (p < 0.0001). This difference was consistent across race and sex sub-groups (p < 0.0001). The PLCOm2012 was more sensitive than the USPSTF in Blacks (69.9% vs. 46.6%, p < 0.0001) and in women (69.8% vs. 41.3%, p < 0.0001). The USPSTF had poor sensitivity for both race groups (Black 46.6%, White 45.9%, p = 0.886) and had lower sensitivity in women vs. men (41.3% vs. 51.4%, p = 0.032). The PLCOm2012 had higher sensitivities in women and men, and difference between sexes was not significant (69.8% vs. 72.6%, p = 0.506).
Compared to the USPSTF 2013 recommendations, the PLCOm2012 model selected a larger proportion of lung cancer cases in all race-sex strata and removed the sex disparity observed for the USPSTF. The PLCOm2012 risk model could be used to identify those who will benefit from LCS.
美国预防服务工作组(USPSTF)的建议并未考虑肺癌风险的种族和性别差异。我们比较了使用 USPSTF 2013 建议与 PLCOm2012 模型在等效阈值下发现有资格接受肺癌筛查(LCS)的肺癌病例的灵敏度。
我们使用乔治敦大学医院肿瘤登记处,确定了 2014 年至 2018 年间年龄≥55 岁的肺癌病例。病历回顾收集了年龄、性别、种族、教育程度、吸烟情况和临床特征。我们比较了总体上以及按种族和性别符合资格标准的百分比。
这些病例(N=447)中 36.6%为黑人,52.6%为女性。PLCOm2012 和 USPSTF 2013 标准分别识别出 71.4%和 45.6%的病例(p<0.0001)。这一差异在种族和性别亚组中是一致的(p<0.0001)。PLCOm2012 在黑人(69.9%比 46.6%,p<0.0001)和女性(69.8%比 41.3%,p<0.0001)中的灵敏度均高于 USPSTF。USPSTF 对两个种族群体的灵敏度都较低(黑人 46.6%,白人 45.9%,p=0.886),女性的灵敏度低于男性(41.3%比 51.4%,p=0.032)。PLCOm2012 在男性和女性中的灵敏度更高,且性别之间的差异无统计学意义(69.8%比 72.6%,p=0.506)。
与 USPSTF 2013 建议相比,PLCOm2012 模型在所有种族-性别分层中选择了更大比例的肺癌病例,并消除了 USPSTF 观察到的性别差异。PLCOm2012 风险模型可用于识别将从 LCS 中受益的人群。